Cytoplasmic p27


Journal

The Journal of pathology
ISSN: 1096-9896
Titre abrégé: J Pathol
Pays: England
ID NLM: 0204634

Informations de publication

Date de publication:
01 2019
Historique:
received: 10 04 2018
revised: 30 08 2018
accepted: 03 09 2018
pubmed: 13 9 2018
medline: 20 12 2019
entrez: 13 9 2018
Statut: ppublish

Résumé

The cell cycle inhibitor p27

Identifiants

pubmed: 30206932
doi: 10.1002/path.5167
doi:

Substances chimiques

CDKN1B protein, human 0
Cdkn1b protein, mouse 0
RHOB protein, human 0
Cyclin-Dependent Kinase Inhibitor p27 147604-94-2
rhoB GTP-Binding Protein EC 3.6.5.2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

60-71

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2018 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Auteurs

Olivier Calvayrac (O)

Cancer Research Center of Toulouse (CRCT), INSERM U1037, CNRS ERL5294, University of Toulouse, Toulouse, France.

Ada Nowosad (A)

LBCMCP, Centre de Biologie Intégrative, Université de Toulouse, CNRS, UPS, Toulouse, France.

Stéphanie Cabantous (S)

Cancer Research Center of Toulouse (CRCT), INSERM U1037, CNRS ERL5294, University of Toulouse, Toulouse, France.

Lin-Po Lin (LP)

Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University, Taipei, Taiwan.

Sarah Figarol (S)

Cancer Research Center of Toulouse (CRCT), INSERM U1037, CNRS ERL5294, University of Toulouse, Toulouse, France.

Pauline Jeannot (P)

LBCMCP, Centre de Biologie Intégrative, Université de Toulouse, CNRS, UPS, Toulouse, France.

Murielle P Serres (MP)

LBCMCP, Centre de Biologie Intégrative, Université de Toulouse, CNRS, UPS, Toulouse, France.

Caroline Callot (C)

LBCMCP, Centre de Biologie Intégrative, Université de Toulouse, CNRS, UPS, Toulouse, France.

Renaud T Perchey (RT)

LBCMCP, Centre de Biologie Intégrative, Université de Toulouse, CNRS, UPS, Toulouse, France.

Justine Creff (J)

LBCMCP, Centre de Biologie Intégrative, Université de Toulouse, CNRS, UPS, Toulouse, France.

Estelle Taranchon-Clermont (E)

Cancer Research Center of Toulouse (CRCT), INSERM U1037, CNRS ERL5294, University of Toulouse, Toulouse, France.
Service de Pathologie, IUCT-Oncopole, CHU de Toulouse, Toulouse, France.

Isabelle Rouquette (I)

Cancer Research Center of Toulouse (CRCT), INSERM U1037, CNRS ERL5294, University of Toulouse, Toulouse, France.
Service de Pathologie, IUCT-Oncopole, CHU de Toulouse, Toulouse, France.

Gilles Favre (G)

Cancer Research Center of Toulouse (CRCT), INSERM U1037, CNRS ERL5294, University of Toulouse, Toulouse, France.

Anne Pradines (A)

Cancer Research Center of Toulouse (CRCT), INSERM U1037, CNRS ERL5294, University of Toulouse, Toulouse, France.

Stephane Manenti (S)

Cancer Research Center of Toulouse (CRCT), INSERM U1037, CNRS ERL5294, University of Toulouse, Toulouse, France.

Julien Mazieres (J)

Cancer Research Center of Toulouse (CRCT), INSERM U1037, CNRS ERL5294, University of Toulouse, Toulouse, France.
Thoracic Oncology Department, Larrey Hospital, University Hospital of Toulouse, Toulouse, France.

Huei Lee (H)

Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University, Taipei, Taiwan.

Arnaud Besson (A)

LBCMCP, Centre de Biologie Intégrative, Université de Toulouse, CNRS, UPS, Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH